Home › Funds › Driehaus Micro Cap Growth Fund
Fund family: DRIEHAUS MUTUAL FUNDS · Filed by DRIEHAUS MUTUAL FUNDS (CIK 1016073) · SEC series S000042829
Ticker: DMCRX (C000132648)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 983 with, 1 against, 0 abstentions (not counted as with management). Shareholder proposals: 1 FOR, 0 AGAINST, 0 abstained, by the filing’s own vote-source field.
Each ballot item this fund voted is set against the votes of the other DRIEHAUS MUTUAL FUNDS funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted the same way as most DRIEHAUS MUTUAL FUNDS funds on all 23 items where a comparison was possible.
The same votes as “with management” above, by the sector of the company voted on. 89.2% of this fund’s 984 such votes could be given a sector; the other 106 (10.8%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Health Care | 249 | 0 | 0.0% |
| Industrials | 169 | 1 | 0.6% |
| Consumer Discretionary | 127 | 0 | 0.0% |
| Technology | 108 | 0 | 0.0% |
| Finance | 74 | 0 | 0.0% |
| Energy | 50 | 0 | 0.0% |
| Basic Materials | 38 | 0 | 0.0% |
| Miscellaneous | 29 | 0 | 0.0% |
| Real Estate | 25 | 0 | 0.0% |
| Consumer Staples | 9 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 660 | 0 |
| Audit-related | 129 | 0 |
| Say-on-Pay | 114 | 0 |
| Compensation | 45 | 0 |
| Corporate Governance | 22 | 0 |
| Capital Structure | 18 | 0 |
| Shareholder Rights and Defenses | 6 | 0 |
| Extraordinary Transactions | 5 | 0 |
| Environment or Climate | 1 | 1 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Spyre Therapeutics, Inc. | May 27, 2026 | $13M | 6 | 0 |
| Praxis Precision Medicines, Inc. | June 10, 2026 | $11M | 5 | 0 |
| Xometry, Inc. | June 16, 2026 | $11M | 5 | 0 |
| TeraWulf Inc. | September 30, 2025 | $11M | 1 | 0 |
| Indivior PLC | December 11, 2025 | $8M | 6 | 0 |
| Edgewise Therapeutics, Inc. | June 4, 2026 | $8M | 5 | 0 |
| FIGS, Inc. | June 3, 2026 | $8M | 5 | 0 |
| Amylyx Pharmaceuticals, Inc. | June 4, 2026 | $8M | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| April 24, 2026 | ArcBest Corporation | A shareholder proposal to approve GHG emissions reduction targets, if properly presented at the Annual Meeting. Shareholder proposal | For | Against |
1,000 ballot items at 132 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Driehaus Micro Cap Growth Fund (DMCRX) voted at 132 shareholder meetings of 127 companies, on 1,000 ballot items in all. Where management made a recommendation, the fund followed it on 99.9% of the items and voted against it 1 time. Its most frequent area of disagreement was environment or climate (1 of its votes against management). It voted on 1 shareholder proposal. It voted the same way as most DRIEHAUS MUTUAL FUNDS funds on every item where a comparison was possible.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026. The interactive database shows the same votes company by company, with every other fund that voted.